BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37148002)

  • 1. Association of P16, Ki-67, and CD44 expression in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of the cervix.
    Mehdi HK; Raju K; Sheela SR
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S260-S267. PubMed ID: 37148002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Stem Cell-associated Transcription Factor SOX2 as a Diagnostic Marker of High-grade Squamous Intraepithelial Lesion of the Uterine Cervix in Comparison With p16 and Ki-67.
    Wolsky RJ; Harbour LN; Mirza KM; Montag AG; Gwin K
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):403-410. PubMed ID: 27490766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.
    Kumar R; Mandal S; Arora P; Mala YM; Khurana N
    J Obstet Gynaecol; 2021 Jul; 41(5):785-790. PubMed ID: 33073644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokeratin7 and cytokeratin19 expression in high grade cervical intraepithelial neoplasm and squamous cell carcinoma and their possible association in cervical carcinogenesis.
    Lee H; Lee H; Cho YK
    Diagn Pathol; 2017 Feb; 12(1):18. PubMed ID: 28212672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of p16 and Ki-67 with Risk of Recurrence in Previously Treated Cervical High-Grade Squamous Intraepithelial Lesions.
    Arredondo-Gálvez CG; Acuña-González D; Cantú-de-León D; Chanona-Vilchis JG; Avilés-Salas A; González-Enciso A; Bandala-Jaques A; Barquet-Muñoz SA
    Gynecol Obstet Invest; 2021; 86(3):293-298. PubMed ID: 34111875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16 and Ki-67 immunostaining in atypical immature squamous metaplasia of the uterine cervix: correlation with human papillomavirus detection.
    Iaconis L; Hyjek E; Ellenson LH; Pirog EC
    Arch Pathol Lab Med; 2007 Sep; 131(9):1343-9. PubMed ID: 17824788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
    Shain AF; Kwok S; Folkins AK; Kong CS
    Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer.
    Kanthiya K; Khunnarong J; Tangjitgamol S; Puripat N; Tanvanich S
    Asian Pac J Cancer Prev; 2016; 17(7):3201-6. PubMed ID: 27509952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.
    Keating JT; Cviko A; Riethdorf S; Riethdorf L; Quade BJ; Sun D; Duensing S; Sheets EE; Munger K; Crum CP
    Am J Surg Pathol; 2001 Jul; 25(7):884-91. PubMed ID: 11420459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of cyclin D1, p16Ink4a, p21WAF1, and Ki-67 correlates with the severity of cervical neoplasia.
    Portari EA; Russomano FB; de Camargo MJ; Machado Gayer CR; da Rocha Guillobel HC; Santos-Rebouças CB; Brito Macedo JM
    Int J Gynecol Pathol; 2013 Sep; 32(5):501-8. PubMed ID: 23896712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of continued upregulation of p16(INK4a) through the evolution from high-grade squamous intraepithelial lesion to invasive squamous carcinoma of the cervix.
    Cheah PL; Looi LM; Mun KS; Abdoul Rahman N; Teoh KH
    Malays J Pathol; 2011 Dec; 33(2):83-7. PubMed ID: 22299207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade squamous intraepithelial lesion (HSIL) of the cervix with bizarre cytological appearances ('pleomorphic HSIL'): a review of 19 cases.
    Stewart CJR
    Pathology; 2017 Aug; 49(5):465-470. PubMed ID: 28666641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of the combined p16 and Ki-67 immunocytochemistry in low-grade squamous intraepithelial lesions.
    Ziemke P; Marquardt K; Griesser H
    Acta Cytol; 2014; 58(5):489-94. PubMed ID: 25342512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests.
    Toll AD; Kelly D; Maleki Z
    Diagn Cytopathol; 2014 Jul; 42(7):576-81. PubMed ID: 24288264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
    Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
    Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
    Cao L; Sun PL; Yao M; Chen S; Gao H
    Hum Pathol; 2017 Jul; 65():194-200. PubMed ID: 28554573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of variable p16 immunostaining patterns, Ki-67 indices and HPV status in cervical SILs and squamous cell carcinomas: An institutional experience.
    Singh P; Kaushik S; Thakur B; Acharya S; Bhardwaj A; Bahal N
    Indian J Pathol Microbiol; 2023; 66(1):63-69. PubMed ID: 36656212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative p16
    Tsiambas E; Riziotis C; Mastronikolis NS; Peschos D; Mortakis A; Kyroysis G; Mastronikolis SN; Batistatou A; Lazaris AC; Patsouris E; Ragos V
    Anticancer Res; 2018 Oct; 38(10):5805-5810. PubMed ID: 30275203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.